Serotonin receptor variants in disease: new therapeutic opportunities?

Ann N Y Acad Sci. 1998 Dec 15:861:16-25. doi: 10.1111/j.1749-6632.1998.tb10168.x.

Abstract

This review describes a novel genetic approach to the assessment of receptor function that is based on association studies of polymorphisms within human genes. The realization that variations within human genes may significantly affect gene function has led to increased use of this approach in recent years. Analysis of polymorphisms within the human 5-HT2A receptor is used as a specific example of the application of association genetics to elucidate gene function. The interaction of many neuroleptics and antidepressants with 5-HT2A receptors points up the potential importance of this receptor for understanding and treating neuropsychiatric disorders such as schizophrenia and depression.

Publication types

  • Review

MeSH terms

  • Antipsychotic Agents / therapeutic use
  • Depressive Disorder / drug therapy
  • Depressive Disorder / genetics
  • Genetic Diseases, Inborn / drug therapy*
  • Genetic Diseases, Inborn / genetics*
  • Genetic Variation*
  • Humans
  • Point Mutation
  • Polymorphism, Genetic
  • Receptors, Serotonin / genetics*
  • Schizophrenia / drug therapy
  • Schizophrenia / genetics

Substances

  • Antipsychotic Agents
  • Receptors, Serotonin